Evidence map›Paper›PMID 39469664›Full record

ArticleTransplant international : official journal of the European Society for Organ Transplantation2024

Tacrolimus Dose Requirement in

Pierre Marquet, Dany Anglicheau, Antoine Humeau, Sofian Adrouche, Lakhdar Saada, Julie Bisiaux, Sara Guillemin, Audrey Lardy-Cléaud, Lionel Rostaing

Abstract readMulticenter Study
PubMed Full text at PMC Publisher
In one paragraph

Article in Transplant international : official journal of the European Society for Organ Transplantation, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Pierre MarquetDepartment of Pharmacology, Toxicology and Pharmacovigilance, Centre Hospitalier Universitaire de Limoges, Limoges, France.
Dany AnglicheauDepartment of Nephrology and Kidney Transplantation, Necker Hospital, Université Paris Cité, Paris, France.
Antoine HumeauPharmacology and Transplantation, UMR1248 Inserm Université de Limoges, Limoges, France.
Sofian AdroucheMedical Department, SANDOZ S.A.S, Levallois-Perret, France.
Lakhdar SaadaMedical Department, SANDOZ S.A.S, Levallois-Perret, France.
Julie BisiauxClinical Operations Department, RCTs, Lyon, France.
Sara GuilleminMedical Writing Department, RCTs, Lyon, France.
Audrey Lardy-CléaudStatistical Department, RCTs, Lyon, France.
Lionel RostaingDepartment of Nephrology, Centre Hospitalier Universitaire de Grenoble, Grenoble, France.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

All the factors potentially influencing tacrolimus dose requirement and combinations thereof have never been thoroughly investigated, precluding accurate prediction of tacrolimus starting dose. This prospective, non-interventional, multicenter study in

Indexed as

Cytochrome P-450 CYP3AImmunosuppressive AgentsKidney Failure, ChronicKidney TransplantationTacrolimusAdultAgedBilirubinCreatinineDose-Response Relationship, DrugFemaleGraft RejectionHumansMaleMiddle AgedProspective StudiesBilirubinCreatinineCytochrome P-450 CYP3AImmunosuppressive AgentsTacrolimusdietethnicitygenetic polymorphismspharmacokinetic variabilitytacrolimus

Identifiers

PMID39469664
PMCPMC11513580

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.